荣昌生物(09995.HK)今日盘中大跌5.95%,引起市场高度关注。消息面上,公司近期遭遇了一系列不利因素,可能是导致股价大幅下跌的主要原因。
首先,荣昌生物的核心技术人员、执行董事何如意突然辞职,此事在业内引起极大关注。核心技术人员离职无疑会对公司持续创新能力带来一定冲击,从而影响投资者对公司长期发展前景的信心。
此外,公司旗舰产品维迪西妥单抗的归属权也遭到质疑。最新消息显示,此单抗可能被计提2亿美元减值,并最终归属于辉瑞(PFE.US)。如果这一消息属实,无疑将严重打击荣昌生物的核心业务和盈利前景。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.